Palantir Foundry will provide the NHS with a software platform to “enable NHS decision makers to best plan use of resources and improve patient care,” the company said in a statement.
Specifically, the NHS will continue to use Palantir Foundry as part of its Covid-19 response, including the planning and operational roll-out of the U.K.'s vaccine program. The contract is for two years.
It will also use Palantir’s software and systems to monitor and collect data to determine how to allocate health and care resources in emerging hot spots where the disease is flaring up, and ensure critical equipment is supplied to the facilities with the greatest need.
Earlier this month, Palantir garnered a $44.4 million contract from the Food and Drug Administration to assist with drug reviews and inspections, possibly including Covid-19 treatments.
Palantir was co-founded by well-known tech investor Peter Thiel in 2004. It went public earlier this year at $7.25 a share.